bausch health companies inc glp-1 receptor agonist medications Agonists Transform Diabetes & Weight Management | MedPharma Global posted on the topic Ambrosia Biosciences, a Boulder, Colorado-based
Description
Blonde L, Klein EJ, Han J, Zhang B, Mac SM, Poon TH, et al
DPP-4 inhibitors: What may be the clinical differentiators
Ghrelin stimulates the secretion of adrenocorticotropic hormone, growth hormone and prolactin and inhibits insulin secretion
Thus, anti-diabetic agents that can attenuate both DKD and CVD have been awaited
Future studies employing sophisticated designs, such as ocular-specific GLP-1 R knockout models, are essential to determine if direct neuroprotective effects can occur independently of systemic metabolic correction
